Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Yui Hui

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Complementary Therapies in Medicine|September 10, 2005
A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patientsVincent Wai-Sun Wong, Man-Yee Law, Alex Yui Hui, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 24, 2004
Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell lineAlex Yui Hui, Alfred Sze-Lok Cheng, Henry Lik-Yuen Chan, et al.
Antiviral Therapy|August 24, 2007
Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis BHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Angel Mei-Ling Chim, et al.
World Journal of Gastroenterology|December 12, 2003
Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatmentHenry Lik-Yuen Chan, May-Ling Wong, Alex Yui Hui, et al.
Antiviral Therapy|July 22, 2006
Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis BHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Alex Yui Hui, et al.
Clinical Transplantation|May 15, 2004
Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxisHenry Lik-Yuen Chan, Albert Ka-Keung Chui, Wan-Yee Lau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 20, 2006
Effect of celecoxib on experimental liver fibrosis in ratAlex Yui Hui, Wai Keung Leung, Henry Lik Yuen Chan, et al.
Antiviral Therapy|August 5, 2008
Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis BVincent Wai-Sun Wong, Grace Lai-Hung Wong, Steven Woon-Choy Tsang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2009
Surrogate end points and long-term outcome in patients with chronic hepatitis BVincent Wai-Sun Wong, Grace Lai-Hung Wong, Angel Mei-Ling Chim, et al.
Journal of Gastroenterology and Hepatology|June 21, 2008
Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese peopleVincent Wai-Sun Wong, Grace Lai-Hung Wong, Steven Woon-Choi Tsang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Complementary Therapies in Medicine|September 10, 2005
A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patientsVincent Wai-Sun Wong, Man-Yee Law, Alex Yui Hui, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 24, 2004
Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell lineAlex Yui Hui, Alfred Sze-Lok Cheng, Henry Lik-Yuen Chan, et al.
Antiviral Therapy|August 24, 2007
Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis BHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Angel Mei-Ling Chim, et al.
World Journal of Gastroenterology|December 12, 2003
Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatmentHenry Lik-Yuen Chan, May-Ling Wong, Alex Yui Hui, et al.
Antiviral Therapy|July 22, 2006
Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis BHenry Lik-Yuen Chan, Vincent Wai-Sun Wong, Alex Yui Hui, et al.
Clinical Transplantation|May 15, 2004
Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxisHenry Lik-Yuen Chan, Albert Ka-Keung Chui, Wan-Yee Lau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 20, 2006
Effect of celecoxib on experimental liver fibrosis in ratAlex Yui Hui, Wai Keung Leung, Henry Lik Yuen Chan, et al.
Antiviral Therapy|August 5, 2008
Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis BVincent Wai-Sun Wong, Grace Lai-Hung Wong, Steven Woon-Choy Tsang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2009
Surrogate end points and long-term outcome in patients with chronic hepatitis BVincent Wai-Sun Wong, Grace Lai-Hung Wong, Angel Mei-Ling Chim, et al.
Journal of Gastroenterology and Hepatology|June 21, 2008
Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese peopleVincent Wai-Sun Wong, Grace Lai-Hung Wong, Steven Woon-Choi Tsang, et al.
Pageof 3